| | | | | | | | | | | |
|
Dockets Management
|
|
| Dockets Entered
On August 4, 2003
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1983V-0383
|
| Laser light show
|
|
|
|
|
| 1998N-0359
|
| Program priorities/Center for Food Safety & Applied Nutritin
|
|
|
|
|
| 1998V-0511
|
| Laser Light Show, Fortress Band Show
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
| 2000P-1443
|
| Stay against approval of Alendronate Sodium Tablets
|
|
|
|
|
| 2000P-1445
|
| Paragraph IV ANDAs/180-Day Exclusivity Purporses
|
|
|
|
|
| 2002D-0228
|
| Implantable Middle Ear Hearing Device
|
|
|
|
|
| 2003N-0161
|
| Medical Devices;Reprocessed Single-Use Devices;Termination
|
|
|
|
|
| 2003N-0294
|
| Risk Management Plans for Opiate Analgesic Drug
|
|
|
|
|
| 2003P-0217
|
| Concept of shared exclusivity for multiple ANDA submitted on the same day
|
|
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
|
|
| 2003P-0321
|
| Refrain from approving an Abbreviated New Drug Application (ANDA's) for Riavirin
|
|
|
|
|
| 2003V-0239
|
| Laser Light Show
|
|
| |
|
| 1983V-0383
|
| Laser light show
|
|
|
|
|
|
|
| VRA 9
|
| HFZ-300 to Rochester Museum and Science Center
|
| Vol #:
|
| 1
|
|
|
|
|
| 1998N-0359
|
| Program priorities/Center for Food Safety & Applied Nutritin
|
|
|
|
|
|
|
| C
95
|
| National Yogurt Assn (NYA)
|
| Vol #:
|
| 7
|
|
|
|
|
| C
96
|
| Cosmetic, Toiletry, and Fragrance Assn (CTFA)
|
| Vol #:
|
| 7
|
|
|
|
|
| 1998V-0511
|
| Laser Light Show, Fortress Band Show
|
|
|
|
|
|
|
| VRA 2
|
| HFZ-300 to Mr. Dennis L. Myers
|
| Vol #:
|
| 1
|
|
|
|
|
| 2000N-1571
|
| Enrofloxacin for Poultry: Opportunity for Hearing
|
|
|
|
|
|
|
| CS
47
|
| HFA-305
|
| Vol #:
|
| 380
|
|
|
|
|
| OR
49
|
| HF-3
|
| Vol #:
|
| 380
|
|
|
|
|
| 2000P-1443
|
| Stay against approval of Alendronate Sodium Tablets
|
|
|
|
|
|
|
| LET
1
|
| HFD-001 to Ivax Pharmaceuticals, Inc.
|
| Vol #:
|
| 1
|
|
|
|
|
| 2000P-1445
|
| Paragraph IV ANDAs/180-Day Exclusivity Purporses
|
|
|
|
|
|
|
| LET
2
|
| HFD-1 to Zenith Goldline Pharmaceuticals
|
| Vol #:
|
| 1
|
|
|
|
|
| 2002D-0228
|
| Implantable Middle Ear Hearing Device
|
|
|
|
|
|
|
|
|
| GDL
2
|
| GUIDANCE
|
| Vol #:
|
| 1
|
|
|
|
|
| NAD
2
|
| FDA
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
| |
|
| 2003N-0161
|
| Medical Devices;Reprocessed Single-Use Devices;Termination
|
|
|
|
|
|
|
| C
2
|
| Guidant Corporation
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003N-0294
|
| Risk Management Plans for Opiate Analgesic Drug
|
|
|
|
|
|
|
| C
1
|
| Curtiss Consulting
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0217
|
| Concept of shared exclusivity for multiple ANDA submitted on the same day
|
|
|
|
|
|
|
| LET
1
Attachment
1, 2
|
| HFD-1 to Venable, Baetjer, Howard & Civiletti, LLP
|
| Vol #:
|
| 1
|
|
|
|
|
| 2003P-0270
|
| Prohibit False and Misleading Labeling
|
|
|
|
|
|
|
| C 20
|
| Jeff Boghosian
|
| Vol #:
|
| 1
|
|
|
|
|
| C 21
|
| Brian Patrick
|
| Vol #:
|
| 1
|
|
|
|
|
| C 22
|
| Brett Wyker
|
| Vol #:
|
| 1
|
|
|
|
|
| C 23
|
| Gretchen A. Dickson
|
| Vol #:
|
| 1
|
|
|
|
|
| C 24
|
| Form Letters
|
| Vol #:
|
| 5
|
|
|
|
|
| 2003P-0321
|
| Refrain from approving an Abbreviated New Drug Application (ANDA's) for Riavirin
|
|
|
|
|
|
|
| LET
1
|
| Hogan & Hartson, LLP
|
| Vol #:
|
| 2
|
|
|
|
|
| 2003V-0239
|
| Laser Light Show
|
|
|
|
|
|
|
| VRA 1
|
| HFZ-300 to GEKD, Inc. dba 1739 Nightclub
|
| Vol #:
|
| 1
|
|
